HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wen G Jiang Selected Research

Hepatitis A Virus Cellular Receptor 1

1/2022Hepatitis A Virus Cellular Receptor 1 (HAVcr-1) Initiates Prostate Cancer Progression in Human Cells via Hepatocyte Growth Factor (HGF)-Induced Changes in Junctional Integrity.
1/2013HAVcR-1 expression in human colorectal cancer and its effects on colorectal cancer cells in vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wen G Jiang Research Topics

Disease

197Neoplasms (Cancer)
10/2022 - 01/2002
135Breast Neoplasms (Breast Cancer)
01/2022 - 08/2003
85Neoplasm Metastasis (Metastasis)
10/2022 - 01/2002
43Prostatic Neoplasms (Prostate Cancer)
01/2022 - 01/2002
26Lung Neoplasms (Lung Cancer)
01/2021 - 12/2005
17Wounds and Injuries (Trauma)
11/2021 - 03/2007
16Stomach Neoplasms (Stomach Cancer)
04/2021 - 11/2012
13Colorectal Neoplasms (Colorectal Cancer)
04/2018 - 07/2009
12Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 10/2005
12Carcinogenesis
03/2019 - 06/2007
10Carcinoma (Carcinomatosis)
01/2021 - 01/2004
8Disease Progression
06/2021 - 05/2015
6Urinary Bladder Neoplasms (Bladder Cancer)
01/2020 - 01/2010
5Pancreatic Neoplasms (Pancreatic Cancer)
06/2021 - 03/2016
5Starvation
10/2017 - 08/2008
4Ductal Carcinoma
10/2017 - 10/2003
4Ovarian Neoplasms (Ovarian Cancer)
02/2017 - 06/2016
4Renal Cell Carcinoma (Grawitz Tumor)
01/2017 - 01/2013
4Melanoma (Melanoma, Malignant)
10/2013 - 04/2011
4Necrosis
01/2013 - 01/2006
3Inflammation (Inflammations)
10/2021 - 12/2015
3Lymphatic Metastasis
03/2017 - 09/2005
3Hypoxia (Hypoxemia)
01/2017 - 10/2007
3Wilms Tumor (Wilm's Tumor)
11/2016 - 12/2004
3Pituitary Neoplasms (Pituitary Adenoma)
05/2015 - 08/2013
3Kidney Neoplasms (Kidney Cancer)
01/2015 - 01/2012
3Wiskott-Aldrich Syndrome
05/2010 - 10/2008
2Adenocarcinoma of Lung
10/2022 - 03/2020

Drug/Important Bio-Agent (IBA)

124Proteins (Proteins, Gene)FDA Link
01/2022 - 12/2003
51Messenger RNA (mRNA)IBA
03/2020 - 09/2003
44Biological ProductsIBA
10/2022 - 05/2005
24Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
01/2022 - 09/2003
22Catalytic RNA (Ribozymes)IBA
05/2017 - 09/2003
20Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
01/2020 - 02/2007
18CytokinesIBA
02/2021 - 09/2002
17Biomarkers (Surrogate Marker)IBA
01/2022 - 06/2011
12Indicators and Reagents (Reagents)IBA
01/2021 - 01/2004
11hammerhead ribozymeIBA
01/2017 - 09/2004
9Cadherins (E-Cadherin)IBA
01/2022 - 06/2005
8Activated-Leukocyte Cell Adhesion Molecule (Neurolin)IBA
10/2021 - 01/2004
8TransglutaminasesIBA
01/2017 - 11/2003
8LigandsIBA
01/2017 - 12/2003
8Growth InhibitorsIBA
01/2017 - 01/2006
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 12/2003
7Small Interfering RNA (siRNA)IBA
04/2021 - 12/2010
7Protein Isoforms (Isoforms)IBA
01/2021 - 04/2006
7yangzheng xiaojiIBA
11/2016 - 07/2012
7Peptide Hydrolases (Proteases)FDA Link
03/2013 - 04/2006
6CateninsIBA
01/2022 - 09/2006
6OsteopontinIBA
01/2021 - 01/2016
6S100 Calcium Binding Protein A7IBA
01/2020 - 07/2004
6N 30IBA
03/2019 - 12/2004
6PaxillinIBA
01/2019 - 09/2008
6InterleukinsIBA
03/2017 - 06/2006
5RNA (Ribonucleic Acid)IBA
01/2021 - 06/2006
5sodium-hydrogen exchanger regulatory factorIBA
03/2020 - 10/2013
5Conditioned Culture MediaIBA
11/2018 - 06/2006
5pigment epithelium-derived factorIBA
04/2018 - 12/2005
5Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2018 - 12/2003
5matriptase 2IBA
03/2013 - 06/2007
5Serine Proteases (Serine Protease)IBA
03/2013 - 06/2007
5Bone Morphogenetic Protein 7IBA
06/2012 - 09/2007
4Paclitaxel (Taxol)FDA LinkGeneric
01/2022 - 12/2017
4Cisplatin (Platino)FDA LinkGeneric
04/2021 - 01/2017
4Protein Kinases (Protein Kinase)IBA
01/2021 - 03/2016
4Cell Adhesion MoleculesIBA
01/2021 - 01/2002
4Telomerase (Telomerase Reverse Transcriptase)IBA
03/2020 - 05/2008
4Bone Morphogenetic Protein ReceptorsIBA
01/2020 - 02/2007
4Focal Adhesion Protein-Tyrosine KinasesIBA
01/2019 - 04/2010
4Matrix Metalloproteinases (MMPs)IBA
05/2017 - 04/2006
4AntigensIBA
03/2016 - 01/2011
4OccludinIBA
03/2016 - 08/2003
4Growth Differentiation Factor 9IBA
03/2012 - 11/2010
4EnzymesIBA
06/2011 - 04/2006
4RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
05/2010 - 12/2005
4matrigelIBA
04/2010 - 03/2005
4Placenta Growth FactorIBA
09/2008 - 12/2003
3Phosphotransferases (Kinase)IBA
01/2022 - 01/2021
3Cyclin D1IBA
01/2022 - 07/2011
3Fluorouracil (Carac)FDA LinkGeneric
04/2021 - 01/2014
3Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
12/2019 - 05/2014
3Epidermal Growth Factor (EGF)IBA
03/2017 - 08/2015
3RANK LigandIBA
01/2017 - 01/2013
3plexinIBA
01/2017 - 01/2014
3Sodium-Hydrogen ExchangersIBA
01/2017 - 10/2013
3Connective Tissue Growth FactorIBA
11/2016 - 12/2004
3Cysteine (L-Cysteine)FDA Link
11/2016 - 12/2004
3A-factor (Streptomyces)IBA
02/2016 - 06/2007
3Proto-Oncogene Proteins c-metIBA
08/2015 - 01/2004
3claudin 16IBA
01/2015 - 09/2008
3Protein Tyrosine PhosphatasesIBA
11/2013 - 01/2012
3Wiskott-Aldrich Syndrome Protein FamilyIBA
11/2010 - 10/2008
3PPAR gammaIBA
12/2006 - 09/2003
3EicosanoidsIBA
04/2006 - 10/2003
2Hepatitis A Virus Cellular Receptor 1IBA
01/2022 - 01/2013
2Crystallins (Crystallin)IBA
01/2022 - 12/2011

Therapy/Procedure

42Therapeutics
11/2021 - 07/2002
11Drug Therapy (Chemotherapy)
01/2022 - 07/2012
5Chinese Traditional Medicine (Traditional Chinese Medicine)
11/2016 - 03/2015
3Aftercare (After-Treatment)
11/2018 - 05/2007